IPP Bureau

GAIASO appoints Dr. Tracey Brown as CEO
GAIASO appoints Dr. Tracey Brown as CEO

By IPP Bureau - September 16, 2025

Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,

Novo Nordisk survey finds Wegovy reduces food noise and improves mental well-being in people with obesity
Novo Nordisk survey finds Wegovy reduces food noise and improves mental well-being in people with obesity

By IPP Bureau - September 16, 2025

The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy

Brenntag expands partnership with Lallemand to deliver Nutrilife baking enzymes across North America
Brenntag expands partnership with Lallemand to deliver Nutrilife baking enzymes across North America

By IPP Bureau - September 16, 2025

Brenntag will supply Food & Nutrition customers in the United States and Canada with Lallemand’s renowned Nutrilife baking enzyme range

Goa to host historic 10th Ayurveda day on September 23
Goa to host historic 10th Ayurveda day on September 23

By IPP Bureau - September 16, 2025

We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav

Prof. P K Prajapati assumes charge as Director of AIIA, New Delhi
Prof. P K Prajapati assumes charge as Director of AIIA, New Delhi

By IPP Bureau - September 16, 2025

Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,

MoS Health Patel inaugurates National Virus Research & Diagnostic Laboratory Conclave 2025
MoS Health Patel inaugurates National Virus Research & Diagnostic Laboratory Conclave 2025

By IPP Bureau - September 16, 2025

Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem

Advent to sell generic drugmaker Zentiva to GTCR
Advent to sell generic drugmaker Zentiva to GTCR

By IPP Bureau - September 16, 2025

Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business

HCHB and element5 form strategic alliance to accelerate the agentic AI movement in post-acute care
HCHB and element5 form strategic alliance to accelerate the agentic AI movement in post-acute care

By IPP Bureau - September 16, 2025

Element5’s Agentic AI platform will be integrated with the HCHB EHR

Kerala to host Ayush Mission workshop on “IT solutions in the Ayush sector”
Kerala to host Ayush Mission workshop on “IT solutions in the Ayush sector”

By IPP Bureau - September 16, 2025

The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,

Philips and Masimo partner to advance access to patient monitoring technologies
Philips and Masimo partner to advance access to patient monitoring technologies

By IPP Bureau - September 16, 2025

Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions

Mycenax and Spera forge alliance to streamline ADC drug substance
Mycenax and Spera forge alliance to streamline ADC drug substance

By IPP Bureau - September 16, 2025

FDA launches crackdown on deceptive drug advertising
FDA launches crackdown on deceptive drug advertising

By IPP Bureau - September 16, 2025

The FDA is beginning rulemaking to close the “adequate provision” loophole

Novo Nordisk’s amylin therapy cagrilintide shows significant weight loss in phase 3 trial
Novo Nordisk’s amylin therapy cagrilintide shows significant weight loss in phase 3 trial

By IPP Bureau - September 16, 2025

Cagrilintide represents a novel approach to obesity management

FDA approves Corstasis’ bumetanide nasal spray to treat edema in heart, liver, and kidney disease
FDA approves Corstasis’ bumetanide nasal spray to treat edema in heart, liver, and kidney disease

By IPP Bureau - September 16, 2025

Galimedix completes phase 1 study with oral small molecule GAL-101
Galimedix completes phase 1 study with oral small molecule GAL-101

By IPP Bureau - September 16, 2025

The study further confirmed that GAL-101 effectively crosses the blood-brain barrier

Latest Stories

Interviews

Packaging